Product Website: www.calquence.com/hcp

Production Information:  CALQUENCE is a Bruton tyrosine kinase (BTK) inhibitor indicated for the treatment of adult patients with mantle cell lymphoma (MCL) who have received at least one prior therapy.

NDC Code: 00310-0512-60   100mg cap  60 count

Companion Diagnostic: NO   

REMs: NO 

Limited Distribution: YES  

Manufacturer Reimbursement Assistance:

Patient Assistance (844) 275-2360 or www.myaccess360.com.  If there are financial barriers to fulfilling this prescription, www.astrazeneca-us.com/medicines/Affordability.html may be able to help.

Online Information:

Direct to patient nurse/clinical support program:

Additional products/supplies for patients:

Professional educational materials available from your sales specialist:

Online Information: